Table 5. Bioassay of disinfected 22L brain homogenate in tga20 mice.

Disinfectant	Dilution of 22L brain homogenate inoculated after treatmenta							Titerb	Log10 Reduction in titer
	10−3	10−4	10−5	10−6	10−7	10−8	10−9
Saline	4/4 c, 94	4/4, 104	4/4, 112	4/4, 126	4/4, 156	1/4, 149	0/4	9.25	NA
4% Wex-cide	1/8, 228	0/8	nt	nt	nt	nt	nt	4.15	5.1
2% eLpH	8/8, 158	2/7, 174	nt	nt	nt	nt	nt	5.3	4.0

^aAliquots of 22L-infected brain homogenates (10%) were exposed to different disinfectants or saline for 30 minutes at a 1:9 ratio. Solutions were then further diluted for bioassay in mice. Each recipient mouse received 30μl of inoculum.

^b The calculated titer reported is the log₁₀LD₅₀ / gram of tissue

^c The numerator is the number of prion-positive mice (see Methods), and the denominator is the number of mice inoculated. For groups with positive mice the average incubation period in days-post inoculation (dpi) is provided. Tga20 mice typically do not develop 22L prion disease after 200 dpi. Mice that did not develop clinical signs of prion disease were euthanized at 289 dpi.

NA = not applicable, nt = not tested